CAPR
CAPRICOR THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$9.06
−3.62%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- -$0.14
- Revenue estimate
- $41.7M
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.70
- EPS estimate
- -$0.59
- Revenue actual
- —
- Revenue estimate
- $2.1M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +0.1%
- Revenue beats (12Q)
- 4
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $27
- PT range
- $25 – $28
- Analysts
- 5
3 Buy2 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.59 | -$0.70 | Miss -18.87% | — |
| May 12, 2026 | -$0.55 | -$0.59 | Miss -7.27% | — |
| Mar 12, 2026 | -$0.51 | -$0.62 | Miss -21.81% | — |
| Mar 19, 2025 | -$0.31 | -$0.16 | Beat 48.39% | $11.1M |
| Feb 29, 2024 | -$0.09 | -$0.02 | Beat 77.78% | $12.1M |
| Nov 14, 2023 | -$0.29 | -$0.25 | Beat 13.79% | $6.2M |
| May 11, 2023 | -$0.32 | -$0.31 | Beat 3.13% | $3.0M |
| Mar 15, 2023 | -$0.33 | -$0.31 | Beat 6.06% | — |
| Nov 10, 2022 | -$0.29 | -$0.26 | Beat 10.34% | $1.6M |
| Aug 10, 2022 | -$0.25 | -$0.29 | Miss -16.00% | — |
| Mar 10, 2022 | -$0.19 | -$0.26 | Miss -36.84% | -$244.7K |
| Aug 12, 2021 | -$0.23 | -$0.21 | Beat 8.70% | $204.1K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026